Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.57 USD | -1.09% | -2.41% | -35.64% |
May. 06 | Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating | MT |
May. 01 | (CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20 | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.32 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Employment Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.64% | 507M | B+ | ||
-10.54% | 9.78B | A- | ||
-19.39% | 7.31B | A- | ||
-12.38% | 6.68B | B+ | ||
-3.28% | 3.67B | A- | ||
-1.32% | 3.51B | C+ | ||
+12.17% | 1.65B | - | ||
+0.21% | 1.52B | - | ||
+11.14% | 1.51B | - | ||
-5.17% | 1.2B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CCRN Stock
- Ratings Cross Country Healthcare, Inc.